Gene: FBXO3
Official Full Name: F-box protein 3provided by HGNC
Gene Summary: This gene encodes a member of the F-box protein family which is characterized by an approximately 40 amino acid motif, the F-box. The F-box proteins constitute one of the four subunits of the ubiquitin protein ligase complex called SCFs (SKP1-cullin-F-box), which function in phosphorylation-dependent ubiquitination. The F-box proteins are divided into 3 classes: Fbws containing WD-40 domains, Fbls containing leucine-rich repeats, and Fbxs containing either different protein-protein interaction modules or no recognizable motifs. The protein encoded by this gene belongs to the Fbxs class. Alternative splicing of this gene generates 2 transcript variants diverging at the 3' end. [provided by RefSeq, Jul 2008]
Catalog Number | Product Name | Species | Gene | Passage ratio | Mycoplasma testing | Price |
---|---|---|---|---|---|---|
GP00330 | FBXO3 gRNA6-gRNA8 KO plasmid | FBXO3 | $850 | |||
GP00334 | FBXO3 gRNA5-gRNA7 KO plasmid | FBXO3 | $850 | |||
KO00691 | FBXO3 Knockout cell line(Hep G2) | Human | FBXO3 | 1:2~1:4 | Negative | Online Inquiry |
KO03264 | FBXO3 Knockout cell line (HeLa) | Human | FBXO3 | 1:3~1:6 | Negative | Online Inquiry |
KO03265 | FBXO3 Knockout cell line (HCT 116) | Human | FBXO3 | 1:2~1:4 | Negative | Online Inquiry |
KO03266 | FBXO3 Knockout cell line (HEK293) | Human | FBXO3 | 1:3~1:6 | Negative | Online Inquiry |
KO03267 | FBXO3 Knockout cell line (A549) | Human | FBXO3 | 1:3~1:4 | Negative | Online Inquiry |
FBXO3 Gene Knockout Cell Lines are specialized cellular models engineered to lack the functional FBXO3 gene, which encodes a protein belonging to the F-box family used in ubiquitin-mediated protein degradation. By knocking out the FBXO3 gene, researchers can investigate the downstream effects of its absence on various cellular processes, such as cell cycle regulation, apoptosis, and response to stress. These cell lines serve as invaluable tools for elucidating the biological roles of FBXO3 and its contributions to physiological and pathological states.
The key mechanism at play in FBXO3 gene knockout involves the disruption of normal protein turnover regulated by the ubiquitin-proteasome pathway. This disruption allows for the analysis of accumulation patterns of substrates typically targeted by FBXO3, enabling scientists to examine signaling pathways involved in cancer, neurodegeneration, and immune responses. Such investigations hold paramount importance in both research and clinical settings, aiding in the discovery of potential therapeutic targets and the development of novel treatment strategies.
Compared to traditional cell lines, the FBXO3 Gene Knockout Cell Lines offer a unique advantage by providing a clean model for studying the specific functions of the FBXO3 protein, free from the confounding effects of other regulatory mechanisms. This specificity allows for precise experimental designs and the generation of more reproducible data. As researchers grapple with complex biological pathways, these knockout models present an innovative solution for dissecting the roles of individual genes.
For researchers and clinicians focused on molecular biology, cancer research, or drug development, FBXO3 Gene Knockout Cell Lines offer a significant value proposition. The ability to manipulate gene expression and observe consequent cellular changes enhances the understanding of disease mechanisms and paves the way for groundbreaking insights into therapeutic interventions.
Our company brings years of expertise in genetic engineering and cell line development, ensuring that our FBXO3 Gene Knockout Cell Lines are produced with the highest standards of quality and precision. By empowering the scientific community with advanced research tools, we continue to support innovative discoveries in biology and medicine.
Please note that all services are for research use only. Not intended for any clinical use.
If your question is not addressed through these resources, you can fill out the online form below and we will answer your question as soon as possible.
There is no product in your cart. |
CD Biosynsis is a leading customer-focused biotechnology company dedicated to providing high-quality products, comprehensive service packages, and tailored solutions to support and facilitate the applications of synthetic biology in a wide range of areas.